tiprankstipranks
Trending News
More News >
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Ownership - Who Owns Moleculin Biotech?

Compare
1,926 Followers

Moleculin Biotech (MBRX) Ownership Overview

35.72%2.84%<0.01%0.31%61.13%
35.72% Insiders
<0.01% Other Institutional Investors
0.31% ETFs
61.13% Public Companies and
Individual Investors
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail, and individual investors. Approximately 3.15% of the company’s stock is owned by Institutional Investors, 35.72% is owned by Insiders, and 61.13% is owned by Public Companies and Individual Investors.
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail, and individual investors. Approximately 2.84% of the company’s stock is owned by Institutional Investors, 35.72% is owned by Insiders, and 0.31% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 23, 2025
xxxxxxxxxxxxx
$250000
Jun 23, 2025
xxxxxxxxxxxxx
$100000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
765,356Insider24.86%3,226,741
303,189Insider9.85%1,278,245
87,486Institution2.84%368,841
16,771Insider0.54%70,707
14,660Insider0.48%61,807
9,448Institution0.31%39,833

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
87,486Institution2.84%368,841

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
9,448Institution0.31%31,273

FAQ

Who Owns Moleculin Biotech (MBRX)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 35.72% is held by insiders, and 61.13% is held by retail investors.
    What percentage of Moleculin Biotech (MBRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Moleculin Biotech (MBRX) stock is held by institutional investors.
      What percentage of Moleculin Biotech (MBRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 61.13% of Moleculin Biotech (MBRX) stock is held by retail investors.
        Who owns the most shares of Moleculin Biotech (MBRX)?
        WALTER V KLEMP owns the most shares of Moleculin Biotech (MBRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.